111 results on '"Sadzot-Delvaux C"'
Search Results
2. Varicella-Zoster Virus IE63, a Virion Component Expressed during Latency and Acute Infection, Elicits Humoral and Cellular Immunity
3. Comparative immunohistochemical study of herpes simplex and varicella-zoster infections
4. Overview of the Replication Cycle of Varicella-Zoster Virus
5. Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections
6. A New Topical Treatment For Resistant Herpes Simplex Infections
7. Meningoradiculoneuritis Due to Acyclovir-Resistant Varicella-Zoster Virus in a Patient with AIDS
8. Varicella vaccination in Europe – taking the practical approach
9. Herpes Simplex Virus Type-I and Pyogenic Granuloma: A Vascular Endothelial Growth Factor-Mediated Association
10. Low-Productive Alpha-Herpesviridae Infection in Chronic Lichenoid Dermatoses
11. La régulation des cycles infectieux du virus de la varicelle et du zona.
12. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
13. Localization of varicella-zoster virus nucleic acids and proteins in human skin
14. Varicella-zoster virus latency in the adult rat is a useful model for human latent infection
15. Varicella-zoster virus induces apoptosis in cell culture
16. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency
17. Viral Glycoproteins in Herpesviridae Granulomas
18. Successful Treatment of Progressive Mucocutaneous Infection Due to Acyclovirand Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine (HPMPC)
19. Meningoradiculoneuritis due to acyclovir‐resistant varicella zoster virus in an acquired immune deficiency syndrome patient
20. Neurotransmitter phenotype plasticity in adult dorsal root ganglia neurons
21. Antibodies to varicella-zoster virus modulate antigen distribution but fail to induce viral persistence in vitro
22. In vitro and in vivo modulation of 5-hydroxytryptamine-, thyrotropin-releasing hormone- and calcitonin-gene related peptide-like immunoreactivities in adult rat sensory neurons
23. Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents
24. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia
25. Acute and persistent varicella-zoster virus infection of human and murine neuroblastoma cell lines
26. Lessons to be learned from varicella-zoster virus
27. Varicella-zoster virus infection of adult rat sensory neurons in vitro
28. [Lethal varicella. Immunohistochemistry and in situ hybridization]
29. Varicella vaccination in Europe – taking the practical approach
30. Varicella vaccination in Europe - taking the practical approach.
31. Varicella-zoster virus recapitulates its immune evasive behaviour in matured hiPSC-derived neurospheroids.
32. Lack of strong innate immune reactivity renders macrophages alone unable to control productive Varicella-Zoster Virus infection in an isogenic human iPSC-derived neuronal co-culture model.
33. Activation of Interferon-Stimulated Genes following Varicella-Zoster Virus Infection in a Human iPSC-Derived Neuronal In Vitro Model Depends on Exogenous Interferon-α.
34. Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4 + GBM cells: A proof of principle.
35. [Contribution of GIGA I3 (GIGA-Infection, Immunity and Inflammation) to the understanding of the complex pathogen-host-environment interplay].
36. Varicella-Zoster Virus ORF9p Binding to Cellular Adaptor Protein Complex 1 Is Important for Viral Infectivity.
37. Deletion of the ORF9p acidic cluster impairs the nuclear egress of varicella-zoster virus capsids.
38. Varicella-zoster virus induces the formation of dynamic nuclear capsid aggregates.
39. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.
40. ORF9p phosphorylation by ORF47p is crucial for the formation and egress of varicella-zoster virus viral particles.
41. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3.
42. Innate immune response and viral interference strategies developed by human herpesviruses.
43. The Varicella-Zoster virus IE4 protein: a conserved member of the herpesviral mRNA export factors family and a potential alternative target in antiherpetic therapies.
44. Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway.
45. Varicella vaccination in Japan, South Korea, and Europe.
46. Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.
47. The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent manner.
48. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine.
49. [Varicelle zoster virus, an alphaherpesvirus different from others].
50. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.